ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,738.17
-0.13%
Dow Jones
42,313.00
0.33%
US Dollar vs MXN
19.71406
0.35%
Brent Oil
71.75
0.06%
Bitcoin
64,581.23
-1.59%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Response Genetics Inc (CE) (RGDXQ)

  7. Response Genetics Inc (CE) (RGDXQ) Noticias

RGDXQ

Response Genetics (CE) (RGDXQ)

Response Genetics Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:RGDXQ
FechaHoraFuenteTítuloSímboloCompañía
11/08/201513:44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGDXQResponse Genetics Inc (CE)
10/07/201508:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:RGDXQResponse Genetics Inc (CE)
15/05/201515:55Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGDXQResponse Genetics Inc (CE)
14/05/201506:00GlobeNewswire Inc.Response Genetics, Inc. Announces First Quarter 2015 Financial ResultsUSOTC:RGDXQResponse Genetics Inc (CE)
07/05/201506:00GlobeNewswire Inc.Response Genetics, Inc. to Release First Quarter 2015 Financial Results and Host Conference Call on May 14, 2015USOTC:RGDXQResponse Genetics Inc (CE)
13/04/201515:38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RGDXQResponse Genetics Inc (CE)
07/04/201517:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGDXQResponse Genetics Inc (CE)
31/03/201515:05GlobeNewswire Inc.Response Genetics, Inc. Announces Fourth Quarter and Year-End 2014 Financial ResultsUSOTC:RGDXQResponse Genetics Inc (CE)
19/03/201513:07GlobeNewswire Inc.Response Genetics, Inc. to Release Fourth Quarter and Year-End 2014 Financial Results and Host Conference Call on March 31, 2...USOTC:RGDXQResponse Genetics Inc (CE)
02/02/201514:13Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:RGDXQResponse Genetics Inc (CE)
29/01/201512:57Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:RGDXQResponse Genetics Inc (CE)
15/01/201513:10GlobeNewswire Inc.Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology's Gastrointestinal Cancers Sympo...USOTC:RGDXQResponse Genetics Inc (CE)
11/12/201406:00GlobeNewswire Inc.Response Genetics Secures New York State Department of Health Approval for the Company's ResponseDX(R) Testing ServicesUSOTC:RGDXQResponse Genetics Inc (CE)
22/08/201405:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RGDXQResponse Genetics Inc (CE)
12/08/201416:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:RGDXQResponse Genetics Inc (CE)
21/07/201416:08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:RGDXQResponse Genetics Inc (CE)
16/06/201406:00GlobeNewswire Inc.Response Genetics Launches New Test for Cancer Immunotherapy Drug DevelopmentUSOTC:RGDXQResponse Genetics Inc (CE)
12/06/201409:07GlobeNewswire Inc.FDA-Cleared, Medicare-Reimbursed, ResponseDX: Tissue of Origin(TM) Test Added to National Institute of Health's (NIH) Genetic...USOTC:RGDXQResponse Genetics Inc (CE)
27/05/201416:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:RGDXQResponse Genetics Inc (CE)
27/05/201416:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:RGDXQResponse Genetics Inc (CE)
14/05/201406:00GlobeNewswire Inc.Response Genetics Expands Distribution of ResponseDX(R) Product Portfolio Into International MarketsUSOTC:RGDXQResponse Genetics Inc (CE)
08/05/201406:00GlobeNewswire Inc.Response Genetics, Inc. Announces First Quarter 2014 Financial ResultsUSOTC:RGDXQResponse Genetics Inc (CE)
01/05/201415:05GlobeNewswire Inc.Response Genetics, Inc. to Release First Quarter 2014 Financial Results and Host Conference Call on May 8, 2014USOTC:RGDXQResponse Genetics Inc (CE)
21/04/201406:00GlobeNewswire Inc.Response Genetics Enters Next Generation Sequencing Market With Proprietary Panel for Lung Cancer Developed by the Knight Can...USOTC:RGDXQResponse Genetics Inc (CE)
04/04/201415:57Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:RGDXQResponse Genetics Inc (CE)
03/04/201406:00GlobeNewswire Inc.Response Genetics, Inc. Announces Contracts With Six New Provider NetworksUSOTC:RGDXQResponse Genetics Inc (CE)
31/03/201414:06Edgar (US Regulatory)Annual Report (10-k)USOTC:RGDXQResponse Genetics Inc (CE)
20/03/201406:00GlobeNewswire Inc.Response Genetics, Inc. Announces Fourth Quarter and Year-End 2013 Financial ResultsUSOTC:RGDXQResponse Genetics Inc (CE)
12/03/201406:00GlobeNewswire Inc.Response Genetics, Inc. to Release Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on March 20, 2...USOTC:RGDXQResponse Genetics Inc (CE)
10/03/201406:00GlobeNewswire Inc.Response Genetics, Inc. to Offer Expanded KRAS Mutation Test to Improve Treatment Decisions for Colorectal Cancer PatientsUSOTC:RGDXQResponse Genetics Inc (CE)
 Showing the most relevant articles for your search:USOTC:RGDXQ

Su Consulta Reciente

COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
COIN
XRPUSD
Ripple
CCOM
US500
US 500
COIN
ADAUSD
Cardano
COIN
BTCUSD
Bitcoin
COIN
AVAXUSD
Avalanche
NYSE
AXP
American Express
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados